Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy

BMJ Open

Volumn 3, Issue 6, 2013, Pages

  Duarte, Rui V ^a,b   Raphael, Jon H ^a,b   Southall, Jane L ^b   Labib, Mourad H ^b   Whallett, Andrew J ^b   Ashford, Robert L ^a  

^a BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; OPIATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPOGONADISM; HYPOPHYSIS GONAD SYSTEM; LONG TERM CARE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; OBSERVATIONAL STUDY; OSTEOPENIA; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 84878761967     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002856     Document Type: Article

References (42)

1. Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981;56:516-20. (Pubitemid 11023593)
2. Grady K, Raphael J. Spinal administration. In: Rice A, ed. Textbook of clinical pain management: chronic volume . London: Hodder Arnold, 2008: 284-91.
3. Nordberg G, Hedner T, Mellstrand T, et al. Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 1984;60:448-54. (Pubitemid 14146220)
4. Bernards C. Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs. Anesthesiology 2006;105:169-78. (Pubitemid 44305206)
5. Duarte RV, Raphael JH, Sparkes E, et al. Long-term intrathecal drug administration for chronic nonmalignant pain. J Neurosurg Anesthesiol 2012; 24: 63-70.
6. Duarte RV, Raphael JH, Haque MS, et al. A predictive model for intrathecal opioid dose escalation for chronic non-cancer pain. Pain Physician 2012; 15: 363-9.
7. Doleys D, Dinoff B, Page L, et al. Sexual dysfunction and other side effects of intraspinal opiate use in the management of chronic non-cancer pain. Am J Pain Manag 1998;8:5-11. (Pubitemid 128167000)
8. Reddy RG, Aung T, Karavitaki N, et al. Opioid induced hypogonadism. BMJ 2010; 341: c4462.
9. Duarte RV, Raphael JH, Mourad L, et al. Prevalence and influence of diagnostic criteria in the assessment of hypogonadism in intrathecal opioid therapy patients. Pain Physician 2013; 16: 9-14.
10. Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain 2009; 25: 170-5.
11. Petak SM, Nankin HR, Spark RF, et al. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update. Endocr Pract 2002; 8: 440-56.
12. Vuong C, Van Uum SHM, O'Dell LE, et al. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010; 31: 98-132.
13. Schulz R, Wilhelm A, Pirke KM, et al. Beta-endorphin and dynorphin control serum luteinizing hormone level in immature female rats. Nature 1981;294:757-9. (Pubitemid 12174447)
14. Pfeiffer DG, Pfeiffer A, Shimohigashi Y, et al. Predominant involvement of mu-rather than delta- or kappa-opiate receptors in LH secretion. Peptides 1983;4:647-9. (Pubitemid 14223707)
15. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72. (Pubitemid 30645223)
16. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929-36. (Pubitemid 34615775)
17. Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215-22. (Pubitemid 32269246)
18. Hackett G, Cole NS, Deshpande AA, et al. Biochemical hypogonadism in men with type 2 diabetes in primary care practice. Br J Diabetes Vasc Dis 2009; 9: 226-31.
19. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385-97.
20. Morley JE. The endocrinology of the opiates and opioid peptides. Metabolism 1981;30:195-209. (Pubitemid 11154404)
21. Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994;9:126-31. (Pubitemid 24105187)
22. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, et al. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 2004;100:851-8. (Pubitemid 38176866)
23. Genazzani AR, Genazzani AD, Volpogni C, et al. Opioid control of gonadotrophin secretion in humans. Hum Reprod 1993;8(Suppl 2):151-3. (Pubitemid 23337196)
24. Finch P, Roberts L, Price L, et al. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000; 16: 251-4.
25. Kinjo M, Setoguchi S, Schneeweiss S, et al. Bone mineral density in subjects using central nervous system-active medications. Am J Med 2005; 118: 1414.
26. Fraser LA, Morrison D, Morley-Forster P, et al. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009; 117: 38-43.
27. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Inter Med 2006;260:76-87. (Pubitemid 43894073)
28. Center JR, Nguyen TV, Sambrook PN, et al. Hormonal and biochemical parameters and osteoporotic fractures in elderly men. J Bone Miner Res 2000; 15: 5-1411.
29. Kanis JA, Melton LJ, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41. (Pubitemid 24985932)
30. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17:1726-33. (Pubitemid 44607392)
31. Center JR, Nguyen TV, Schneider D, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999;353:878-82. (Pubitemid 29126875)
32. Amin S, Zhang Y, Sawin CT, et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 2000;133:951-63. (Pubitemid 32003511)
33. Mellström D, Johnell O, Ljunggren O, et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 2006; 21: 529-35.
34. Lorentzon M, Swanson C, Andersson N, et al. Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study. J Bone Miner Res 2005;20:1334-41. (Pubitemid 41033517)
35. Vanbillemont G, Lapauw B, Bogaert V, et al. Sex hormone-binding globulin as an independent determinant of cortical bone status in men at the age of peak bone mass. J Clin Endocrinol Metab 2010; 95: 1579-86.
36. Hoppé E, Bouvard B, Royer M, et al. Sex hormone-binding globulin in osteoporosis. Joint Bone Spine 2010; 77: 306-12.
37. Khosla S. Sex hormone binding globulin: inhibitor or facilitator (or both) of sex steroid action? J Clin Endocrinol Metab 2006;91:4764-6. (Pubitemid 44917303)
38. Harman S, Metter E, Tobin J, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001;86:724-31. (Pubitemid 32207487)
39. Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005;20:1185-94. (Pubitemid 40863806)
40. Katznelson L, Finkelstein JS, Schoenfeld DA, et al . Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996;81:4358-65. (Pubitemid 26412044)
41. Snyder PJ, Peachey H, Berlin JA, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000;85:2670-7. (Pubitemid 32269134)
42. Daniell HW, Lentz R, Mazer NA. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 2006;7:200-10. (Pubitemid 43324996)